FORM 6-K
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington D.C. 20549

 
 
 
 
 
Report of Foreign Private Issuer
 
 
 
Pursuant to Rule 13a-16 or 15d-16
 
of the Securities Exchange Act of 1934
 
 
 
For October 27, 2017
 
Commission File Number: 001-10306

 
 
 
The Royal Bank of Scotland Group plc

 
 
 
RBS, Gogarburn, PO Box 1000
 
Edinburgh EH12 1HQ

 
 
 
(Address of principal executive offices)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
 
 
   Form 20-F X Form 40-F ___
 
 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):_________

 
 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):_________

 
 
 
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes ___ No X

 
 
 
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________

 
 
 
 
 
 
 
 
The following information was issued as Company announcements in London, England and is furnished pursuant to General Instruction B to the General Instructions to Form 6-K: 
 
 
 
 
 
 
 
 
 
 
The Royal Bank of Scotland Group plc
Q3 2017 Interim Management Statement
Highlights
 
Our strategy
RBS is progressing with its plan to build a strong, simple, fair bank for customers and shareholders, and remains committed to achieving its target of being the number one bank for customer service, trust and advocacy by 2020. In order to achieve this ambition, our strategic priorities and long term targets remain as follows:
 
●
Strength and sustainability - CET1 ratio of 13% and a return on tangible equity of 12% or above;
●
Customer experience - number one for service, trust and advocacy;
●
Simplifying the bank - cost:income ratio of less than 50%;
●
Supporting sustainable growth - leading market positions in every franchise; and
●
Employee engagement - employee engagement in upper quartile of Global Financial Services norm.
 
Q3 2017 RBS highlights
Headline performance
●
RBS reported a profit before tax of £871 million and an attributable profit(1) of £392 million for Q3 2017, the third successive quarter of profit, and an attributable profit of £1,331 million for the year to date.
●
Return on tangible equity was 4.5% for the quarter, and 5.2% for the year to date, with a core(2) adjusted return on equity of 15.0% in Q3 2017.
●
RBS delivered positive operating JAWS(3) of 19.9% for the year to date.
●
Net interest margin (NIM) reduced by 1 basis point to 2.12% compared with Q2 2017. Excluding various one-off interest income releases impacting Capital Resolution and Centre, NIM reduced by 7 basis points with 4 basis points driven by a build up in liquidity and the remainder due to continued structural hedge roll-off and ongoing margin pressure associated with mortgage balance growth.
●
RBS remains on track to achieve all of its 2017 financial targets.
 
Delivering against our 2017 ambition
RBS’s stated ambition for the year is to grow income, cut costs and use less capital across its core businesses and to make progress on resolving legacy issues. In Q3 2017 we have continued to make progress against this ambition.
 
●
Grow income: Across the core businesses, adjusted income has increased by 5.6% in Q3 2017 compared with Q3 2016 and has increased by 7.5% for the year to date.
●
Cut costs: Excluding VAT recoveries, adjusted operating expenses have reduced by £708 million for the year to date, with 33% delivered by the core businesses, and we remain on track to meet our full year £750 million cost reduction target.
●
Reduce capital usage: Excluding volume growth, core RWAs have reduced £10.2 billion for the year to date.
●
Resolve legacy issues: Capital Resolution RWAs reduced by a further £3.5 billion in the quarter to £23.1 billion, or £16.1 billion excluding RBS’s stake in Alawwal Bank. In addition, RBS has received formal approval from the European Commission for its alternative remedies package in respect of Williams & Glyn. This quarter is the last time we will report Capital Resolution and Williams & Glyn separately.
 
Continued loan growth while remaining within our risk appetite
●
Across PBB and CPB, net loans and advances increased by 3.4% on an annualised basis for the year to date, largely driven by mortgage growth within UK PBB, and we remain on track to meet our 3% full year target.
●
A net impairment charge of £143 million, 17 basis points of gross customer loans, was reported in Q3 2017. Risk elements in lending (REIL) were £9.0 billion, representing 2.7% of gross customer loans compared with 2.8% at Q2 2017. Within UK PBB, LTV on the mortgage portfolio was 56%, in line with FY 2016, and LTV on new mortgage lending was 70% for the year to date.
 
Building a stronger RBS
●
RBS continued to strengthen its capital position; CET1 ratio increased by 70 basis points in the quarter to 15.5% reflecting continued RWA reduction, the attributable profit and a reduction in the prudential valuation capital deduction, broadly offsetting the Capital Resolution losses taken in the quarter.
●
Leverage ratio increased by 20 basis points in the quarter to 5.3%.
●
Fully diluted tangible net asset value per ordinary share was stable at 298p.
●
Employee engagement has improved by 7 points to 83 (1 point above GFS Norm) meeting our target for 2017.
●
RBSG’s Commercial Banking franchise NPS is significantly ahead of its three biggest competitors, however more work is required to close the gap in some of our other target segments.
For notes refer to page 3.
 

 
 
Summary consolidated results
 
 
Summary consolidated income statement for the period ended 30 September 2017
 
 
 
 
 
 
 
 
Nine months ended
 
Quarter ended
 
30 September
30 September
 
30 September
30 June
30 September
 
2017 
2016 
 
2017 
2017 
2016 
 
£m
£m
 
£m
£m
£m
Net interest income
6,776 
6,500 
 
2,304 
2,238 
2,167 
 
 
 
 
 
 
 
Own credit adjustments
(78)
294 
 
(5)
(44)
(156)
(Loss)/gain on redemption of own debt
(7)
(127)
 
- 
(9)
3 
Strategic disposals
156 
164 
 
- 
156 
(31)
Other non-interest income
3,229 
2,543 
 
858 
1,366 
1,327 
 
 
 
 
 
 
 
Non-interest income
3,300 
2,874 
 
853 
1,469 
1,143 
 
 
 
 
 
 
 
Total income
10,076 
9,374 
 
3,157 
3,707 
3,310 
 
 
 
 
 
 
 
Litigation and conduct costs
(521)
(1,740)
 
(125)
(342)
(425)
Restructuring costs
(1,034)
(1,099)
 
(244)
(213)
(469)
Other expenses
(5,440)
(6,001)
 
(1,774)
(1,844)
(2,017)
 
 
 
 
 
 
 
Operating expenses
(6,995)
(8,840)
 
(2,143)
(2,399)
(2,911)
 
 
 
 
 
 
 
Profit before impairment losses
3,081 
534 
 
1,014 
1,308 
399 
Impairment losses
(259)
(553)
 
(143)
(70)
(144)
 
 
 
 
 
 
 
Operating profit/(loss) before tax
2,822 
(19)
 
871 
1,238 
255 
Tax charge
(992)
(922)
 
(265)
(400)
(582)
 
 
 
 
 
 
 
Profit/(loss) for the period
1,830 
(941)
 
606 
838 
(327)
 
 
 
 
 
 
 
Attributable to:
 
 
 
 
 
 
Non-controlling interests
21 
37 
 
(8)
18 
7 
Other owners
478 
343 
 
222 
140 
135 
Dividend access share
- 
1,193 
 
- 
- 
- 
Ordinary shareholders
1,331 
(2,514)
 
392 
680 
(469)
 
 
 
 
 
 
 
Memo items:
 
 
 
 
 
 
Total income - adjusted (4)
10,005 
9,043 
 
3,162 
3,604 
3,494 
Operating expenses - adjusted (5)
(5,440)
(6,001)
 
(1,774)
(1,844)
(2,017)
Operating profit - adjusted (6)
4,306 
2,489 
 
1,245 
1,690 
1,333 
 
 
Performance key metrics and ratios
 
 
 
 
 
 
Net interest margin
2.16%
2.18%
 
2.12%
2.13%
2.17%
Average interest earning assets
£419,450m
£398,943m
 
£430,962m
£421,981m
£397,345m
Cost:income ratio (7)
69.1%
94.2%
 
67.5%
64.4%
87.8%
Cost:income ratio - adjusted (4,5,7)
53.9%
65.9%
 
55.6%
50.7%
57.3%
Earnings/(loss) per share
 
 
 
 
 
 
  - basic
11.2p
(21.5p)
 
3.3p
5.7p
(3.9p)
  - basic fully diluted
11.2p
(21.5p)
 
3.3p
5.7p
(3.9p)
  - adjusted basic (4,5)
22.3p
(1.6p)
 
5.9p
9.2p
3.9p
  - adjusted fully diluted (4,5,8)
22.3p
(1.6p)
 
5.9p
9.2p
3.9p
Return on tangible equity (9,10)
5.2%
(8.5%)
 
4.5%
8.0%
(4.8%)
Return on tangible equity - adjusted (4,5,10)
10.4%
(0.6%)
 
8.2%
12.9%
4.6%
Average tangible equity (10)
£33,964m
£39,516m
 
£34,465m
£33,974m
£38,696m
Average number of ordinary shares
 
 
 
 
 
 
 outstanding during the period (millions)
 
 
 
 
 
 
   - basic
11,840 
 11,668 
 
11,886 
 11,841 
 11,724 
  - fully diluted (8)
11,913 
11,709 
 
11,943 
11,923 
11,764 
 
 
 
 
 
 
 
For notes to this table refer to the following page.
 
 
 
 
 
 
 
 

 
 
 
 
Summary consolidated results
 
 
 
30 September
30 June
31 December
Balance sheet related key metrics and ratios
2017 
2017 
2016 
Total assets
£751.8bn
£782.7bn
£798.7bn
Funded assets (11)
£580.0bn
£589.1bn
£551.7bn
Loans and advances to customers (excludes reverse repos)
£324.7bn
£326.1bn
£323.0bn
Customer deposits (excludes repos)
£359.9bn
£359.9bn
£353.9bn
 
 
 
 
Liquidity coverage ratio (LCR) (12,13)
147%
145%
123%
Liquidity portfolio
£177bn
£178bn
£164bn
Net stable funding ratio (NSFR) (14)
126%
123%
121%
Loan:deposit ratio (15)
90%
91%
91%
Risk elements in lending
£9.0bn
£9.3bn
£10.3bn
Impairment provisions
£3.9bn
£3.9bn
£4.5bn
Short-term wholesale funding (15,16)
£21bn
£18bn
£14bn
Wholesale funding (15,16)
£69bn
£70bn
£59bn
 
 
 
 
Common Equity Tier 1 (CET1) ratio
15.5%
14.8%
13.4%
Total capital ratio
20.6%
20.0%
19.2%
Risk-weighted assets (RWAs)
£210.6bn
£215.4bn
£228.2bn
CRR leverage ratio (17)
5.3%
5.1%
5.1%
UK leverage ratio (18)
6.0%
5.8%
5.6%
 
 
 
 
Tangible net asset value (TNAV) per ordinary share (10)
299p
300p
296p
Tangible net asset value (TNAV) per ordinary share - fully diluted (10)
298p
298p
294p
Tangible equity (10)
£35,621m
£35,682m
£34,982m
Number of ordinary shares in issue (millions) (19)
11,905 
11,876 
11,823 
Number of ordinary shares in issue (millions) - fully diluted (8,19)
11,950 
11,956 
11,906 
 
 
Notes:
(1)
Attributable to ordinary shareholders.
(2)
Core business comprises Personal & Business Banking (PBB), Commercial & Private Banking (CPB) and NatWest Markets.
(3)
JAWS represents the combined net growth / reduction in income and costs over the period.
(4)
Excluding own credit adjustments, (loss)/gain on redemption of own debt and strategic disposals.
(5)
Excluding restructuring costs and litigation and conduct costs.
(6)
Operating profit before tax excluding own credit adjustments, (loss)/gain on redemption of own debt, strategic disposals, restructuring, litigation and conduct costs.
(7)
Operating lease depreciation included in income (nine months ended 30 September 2017 - £107 million; Q3 2017 - £35 million; nine months ended 30 September 2016 - £115 million; Q2 2017 - £36 million, Q3 2016 - £39 million).
(8)
Includes the effect of dilutive share options and convertible securities. Dilutive shares on an average basis for Q3 2017 were 57 million shares and for the nine months ended 30 September 2017 were 73 million (Q2 2017 – 82 million; Q3 2016 – 40 million; nine months ended 30 September 2016 – 41 million) and as at 30 September 2017 were 45 million (30 June 2017 – 80 million; 31 December 2016 – 83 million).
(9)
Calculated using profit/(loss) for the period attributable to ordinary shareholders.
(10)
Tangible equity is equity attributable to ordinary shareholders less intangible assets.
(11)
Total assets less derivatives.
(12)
On 1 October 2015 the LCR became the Prudential Regulation Authority’s (PRA) primary regulatory liquidity standard; UK banks are required to meet a minimum standard of 90% from 1 January 2017, rising to 100% by 1 January 2018. The published LCR excludes Pillar 2 add-ons. RBS calculates the LCR using its own interpretation of the EU LCR Delegated Act, which may change over time and may not be fully comparable with those of other institutions.
(13)
The LCR of 145% at 30 June 2017 excludes the impact of the litigation settlement with the FHFA in respect of claims relating to RBS issuance and underwriting of RMBS in the US, as announced on 12 July 2017. The estimated impact of the settlement on the LCR was a 6% reduction to 139% as at 30 June 2017. The LCR of 147% at 30 September 2017 includes the impact of settling with the FHFA.
(14)
NSFR for all periods have been calculated using RBS’s current interpretations of the revised BCBS guidance on NSFR issued in late 2014. Therefore, reported NSFR will change over time with regulatory developments. Due to differences in interpretation, RBS’s ratio may not be comparable with those of other financial institutions.
(15)
Excludes repurchase agreements and stock lending.
(16)
Excludes derivative collateral.
(17)
Based on end-point Capital Requirements Regulation (CRR) Tier 1 capital and leverage exposure under the CRR Delegated Act.
(18)
Based on end-point CRR Tier 1 capital and UK leverage exposures reflecting the post EU referendum measures announced by the Bank of England in the third quarter of 2016.
(19)
Includes 17 million treasury shares (30 June 2017 – 17 million; 31 December 2016 – 39 million).
 
 
 
 

 
 
 
 
Analysis of results
 
Q3 2017 progress
PBB, CPB & NatWest Markets businesses
Grow income
Across the core businesses, adjusted income has increased by 7.5% for the year to date and by 5.6% in Q3 2017 compared with Q3 2016. Across Personal & Business Banking (PBB) and Commercial & Private Banking (CPB), income growth has been supported by increased lending, with net loans and advances 3.6% higher than Q3 2016. NatWest Markets adjusted income was 14.4% higher for the year to date as the business continues to navigate markets well.
 
On an annualised basis, PBB and CPB net loans and advances have increased by 3.4% in the first nine months of the year, with mortgage growth driving an 8.4% increase in UK PBB. Gross new mortgage lending was £7.1 billion with market share of new mortgages at approximately 10%, supporting growth in stock share to approximately 9.2%. Mortgage approval share was around 14% in the quarter, up from 12% in Q2 2017. Across CPB, net loans and advances have reduced by 2.1% on an annualised basis as growth in targeted segments has been more than offset by active capital management of our lending book.
 
Cut costs
Across the core businesses, adjusted operating expenses have reduced £231 million for the year to date, representing 33% of the £708 million reduction achieved across the bank. Cost:income ratio across the core bank improved to 53.1% for the year to date compared with 59.8% for the equivalent period in 2016, with operating JAWS of 11.8%.
 
RBS now has 5.2 million customers regularly using its mobile app, 14% higher than December 2016. Within UK PBB, digital service transactions were 7% higher than Q3 2016 and in Q3 2017 more than 60% of existing customers transferring to a new fixed rate mortgage deal switched digitally. New Bankline, our new best in class commercial web access tool, continues to be rolled out, simplifying the customer experience and saving customers’ time.
 
Reduce capital usage
Excluding volume growth, RWAs reduced by £10.2 billion across the core businesses for the year to date and we remain committed to achieving a gross RWA reduction of at least £20 billion by the end of 2018. The reduction comprised £0.5 billion in PBB, £6.3 billion in CPB and £3.4 billion in NatWest Markets.
 
Capital Resolution and legacy issues
Capital Resolution RWAs reduced by a further £3.5 billion in the quarter to £23.1 billion, or £16.1 billion excluding RBS’s stake in Alawwal Bank (£7.0 billion as at 30 September 2017), already towards the lower end of our £15 - £20 billion full year guidance. Disposal losses, other adjustments and impairments of £375 million were incurred in Q3 2017, although the charge is broadly CET1 neutral as the prudential valuation adjustment increase taken in Q2 2017 in anticipation of these losses has largely reversed. It remains our intention to wind up Capital Resolution during Q4 2017 and transfer the remaining assets back into the rest of the bank.
 
Williams & Glyn
On 18 September 2017 RBS announced that it had received confirmation from the European Commission that the alternative remedies package regarding Williams & Glyn, announced on 26 July 2017, had been formally approved in the form proposed. In full year 2017 reporting we will no longer report Williams & Glyn as a separate segment, but include as part of UK PBB.
 
Outlook (1)
We retain the 2017 full year financial guidance and medium term financial outlook we provided in the 2016 Annual Results document. In addition, and subject to any further provisions for the investigations of the US Department of Justice into the Group’s historic RMBS related activities being substantially taken in 2017, our expectation remains that we will be profitable in 2018.
 
On 24 October 2017, RBS completed the disposal of its shares in Euroclear for a cash consideration of €275 million. RBS expects to recognise a gain on disposal before tax of around £175 million in Q4 2017.
 
Note:
(1) 
The targets, expectations and trends discussed in this section represent management’s current expectations and are subject to change, including as a result of the factors described in this document and in the “Risk Factors” on pages 432 to 463 of the Annual Report and Accounts 2016. These statements constitute forward-looking statements; refer to Forward-looking statements in this announcement.
 
 

 
 
Analysis of results
 
Nine months ended
Quarter ended
 
30 September
30 September
 
30 September
30 June
30 September
 
2017 
2016 
 
2017 
2017 
2016 
Operating profit/(loss) before tax
£m
£m
 
£m
£m
£m
Statutory operating profit/(loss)
2,822 
(19)
 
871 
1,238 
255 
Adjusted for
 
 
 
 
 
 
Own credit adjustments
78 
(294)
 
5 
44 
156 
Loss/(gain) on redemption of own debt
7 
127 
 
 - 
9 
(3)
Strategic disposals
(156)
(164)
 
 - 
(156)
31 
Litigation and conduct costs
521 
1,740 
 
125 
342 
425 
Restructuring costs
1,034 
1,099 
 
244 
213 
469 
Adjusted operating profit
4,306 
2,489 
 
1,245 
1,690 
1,333 
 
 
 
 
 
 
 
PBB, CPB & NWM - adjusted operating profit
4,072 
3,401 
 
1,394 
1,352 
1,331 
 
 
●
Adjusted operating profit reduced by 6.6% compared with Q3 2016 largely reflecting increased losses in Capital Resolution, up £248 million to £366 million.
●
Across the core businesses adjusted operating profit increased by 4.7%. UK PBB increased by 32.3%, benefiting from a £168 million debt sale gain. Partially offsetting this, lower income drove a £89 million reduction in NatWest Markets adjusted operating profit.
●
Compared with Q2 2017, adjusted operating profits were £445 million lower reflecting increased Capital Resolution losses, lower IFRS volatility gains (£21 million compared with £172 million in Q2 2017) and higher impairment losses in Commercial Banking, partially offset by the debt sale gain in UK PBB.
 
 
 
 
 
 
 
 
 
 
Nine months ended
 
Quarter ended
 
30 September
30 September
 
30 September
30 June
30 September
 
2017 
2016 
 
2017 
2017 
2016 
Total income
£m
£m
 
£m
£m
£m
 
 
 
 
 
 
 
Statutory total income
10,076 
9,374 
 
3,157 
3,707 
3,310 
Adjusted for
 
 
 
 
 
 
Own credit adjustments
78 
(294)
 
5 
44 
156 
Loss/(gain) on redemption of own debt
7 
127 
 
 - 
9 
(3)
Strategic disposals
(156)
(164)
 
 - 
(156)
31 
Adjusted total income
10,005 
9,043 
 
3,162 
3,604 
3,494 
 
 
 
 
 
 
 
PBB, CPB & NWM - adjusted total income
9,587 
8,916 
 
3,290 
3,143 
3,115 
 
 
 
 
 
 
 
Notable items within adjusted total income
 
 
 
 
 
 
IFRS volatility in Central items (1)
175 
(818)
 
21 
172 
(150)
UK PBB debt sale gain
176 
4 
 
168 
 - 
 - 
Commercial Banking disposal gain
52 
 - 
 
52 
 - 
 - 
FX reserve (loss)/gain in Central items
(37)
97 
 
(37)
 - 
97 
Unwind of securitisations in the property portfolio
(105)
 - 
 
 - 
 - 
 - 
FX (losses)/gains in Central items
(138)
209 
 
(30)
(56)
(44)
Capital Resolution disposal losses
 
 
 
 
 
 
  and other adjustments
(549)
(166)
 
(446)
(53)
(113)
 
 
●
Excluding a £168 million debt sale gain, UK PBB adjusted income increased by 3.3% compared with Q3 2016 as increased mortgage lending has more than offset margin pressure. Excluding the impact of foreign exchange movements, Ulster Bank RoI adjusted income reduced by 2.9% due to lower income on free funds and one-off items in Q3 2016.
●
Commercial Banking adjusted income increased by 9.3% compared with Q3 2016 reflecting a £52 million asset disposal gain, increased deposit volumes and re-pricing benefits. RBS International increased by 4.3% whilst Private Banking income was stable at £166 million.
●
NatWest Markets adjusted income of £401 million was 23.8% lower than Q3 2016 which benefited from heightened customer activity and favourable market conditions following the EU referendum and central bank actions.
●
Compared with Q2 2017, adjusted income was £442 million lower reflecting increased Capital Resolution losses, reduced IFRS volatility gains and lower NatWest Markets income, partially offset by the debt sale gain in UK PBB.
 
Note:
(1) IFRS volatility relates to loans which are economically hedged but for which hedge accounting is not permitted under IFRS.
 
 

 
 
Analysis of results
 
Nine months ended
 
Quarter ended
 
30 September
30 September
 
30 September
30 June
30 September
 
2017 
2016 
 
2017 
2017 
2016 
Net interest margin
%
%
 
%
%
%
 
 
 
 
 
 
 
Net interest margin (NIM)
2.16%
2.18%
 
2.12%
2.13%
2.17%
 
 
●
NIM reduced by 5 basis points versus Q3 2016 principally reflecting increased liquidity requirements and asset margin pressure.
●
Compared with Q2 2017, NIM reduced by 1 basis point. Excluding various one-off interest income releases impacting Capital Resolution and Centre, NIM reduced by 7 basis points with 4 basis points driven by a build up in liquidity and the remainder due to continued structural hedge roll-off and ongoing margin pressure associated with mortgage balance growth.
●
The sensitivity of net interest earnings, over the next 12 months, to an immediate increase of 25 basis points to all interest rates is c.£175 million across all currencies.
 
 
 
 
 
 
 
 
 
 
Nine months ended
 
Quarter ended
 
30 September
30 September
 
30 September
30 June
30 September
 
2017 
2016 
 
2017 
2017 
2016 
Operating expenses
£m
£m
 
£m
£m
£m
 
 
 
 
 
 
 
Statutory operating expenses
6,995 
8,840 
 
2,143 
2,399 
2,911 
Adjusted for
 
 
 
 
 
 
Litigation and conduct costs
(521)
(1,740)
 
(125)
(342)
(425)
Restructuring costs
(1,034)
(1,099)
 
(244)
(213)
(469)
Adjusted operating expenses
5,440 
6,001 
 
1,774 
1,844 
2,017 
PBB, CPB & NWM - adjusted operating expenses
5,144 
5,375 
 
1,693 
1,702 
1,773 
 
 
 
 
 
 
 
Notable items within adjusted operating expenses
 
 
 
 
 
 
VAT recovery in Central items
(80)
(227)
 
(29)
 - 
 - 
 
 
 
 
 
 
 
Notable items within restructuring costs
 
 
 
 
 
 
Property exit costs
203 
 - 
 
(14)
(18)
 - 
Williams and Glyn restructuring costs
75 
646 
 
17 
46 
301 
 
 
●
UK PBB adjusted operating expenses reduced by 2.6% compared with Q3 2016 reflecting reduced headcount coupled with process and productivity improvements, partially offset by increased technology infrastructure costs. Excluding the impact of foreign exchange movements, Ulster Bank RoI adjusted operating expenses reduced by 5.8%.
●
Commercial Banking adjusted operating expenses reduced 6.0% compared with Q3 2016 reflecting cost efficiencies and a 15.5% reduction in headcount. Cost efficiencies also drove an 8.3% reduction in Private Banking adjusted operating expenses. RBSI increased 22.5% reflecting increased investment spend and regulatory expenses, in part associated with the creation of a bank outside the ring-fence.
●
NatWest Markets adjusted operating expenses were 10.5% lower than Q3 2016 principally due to the prior year including a one-off expense adjustment for investment spend that had previously been capitalised.
●
Capital Resolution adjusted operating expenses reduced by 64.7% to £61 million compared with Q3 2016.
●
Compared with Q2 2017, adjusted operating expenses of £1,774 million were £70 million lower and included a £29 million VAT recovery.
 
 
 
Nine months ended
 
Quarter ended
 
30 September
30 September
 
30 September
30 June
30 September
 
2017 
2016 
 
2017 
2017 
2016 
Impairment losses
£m
£m
 
£m
£m
£m
 
 
 
 
 
 
 
Impairment losses
259 
553 
 
143 
70 
144 
 
 
 
 
 
 
 
Notable items within impairment losses
 
 
 
 
 
 
Capital Resolution impairment (releases)/losses
(149)
383 
 
(71)
(33)
120 
Ulster Bank RoI impairment (releases)/losses
(21)
(66)
 
(10)
13 
(39)
Commercial Banking impairment losses
245 
123 
 
151 
33 
20 
 
 
●
UK PBB reported a net impairment loss of £67 million, 19 basis points of gross customer loans, £40 million higher than Q3 2016 primarily reflecting reduced provision releases. Defaults remain low across all portfolios.
●
Commercial Banking reported a net impairment loss of £151 million in the quarter.
●
Capital Resolution reported a net impairment release of £71 million compared with a charge of £120 million in Q3 2016, which included a £190 million charge in respect of the shipping portfolio.
●
Compared with Q2 2017, impairments increased by £73 million reflecting higher impairment losses in Commercial Banking.
 

 
 
Analysis of results
 
 
 
 
 
 
 
End-point CRR basis (1)
 
30 September 
30 June 
31 December 
 
2017 
2017 
2016 
Risk asset ratios
% 
% 
% 
 
 
 
 
CET1
15.5 
14.8 
13.4 
Tier 1
17.4 
16.7 
15.2 
Total
20.6 
20.0 
19.2 
 
 
 
 
Capital
£m
£m
£m
Tangible equity
35,621 
35,682 
34,982 
 
 
 
 
Expected loss less impairment provisions
(1,197)
(1,226)
(1,371)
Prudential valuation adjustment
(459)
(854)
(532)
Deferred tax assets
(865)
(877)
(906)
Own credit adjustments
(110)
(142)
(304)
Pension fund assets
(185)
(186)
(208)
Cash flow hedging reserve
(298)
(575)
(1,030)
Other adjustments for regulatory purposes
51 
52 
(8)
 
 
 
 
Total deductions
(3,063)
(3,808)
(4,359)
CET1 capital
32,558 
31,874 
30,623 
AT1 capital
4,041 
4,041 
4,041 
Tier 1 capital
36,599 
35,915 
34,664 
Tier 2 capital
6,841 
7,107 
9,161 
 
 
 
 
Total regulatory capital
43,440 
43,022 
43,825 
 
 
 
 
Risk-weighted assets
 
 
 
 
 
 
 
Credit risk
 
 
 
  - non-counterparty
154,400 
157,300 
162,200 
  - counterparty
16,000 
17,800 
22,900 
Market risk
16,400 
16,500 
17,400 
Operational risk
23,800 
23,800 
25,700 
 
 
 
 
Total RWAs
210,600 
215,400 
228,200 
 
 
 
 
Leverage (2)
 
 
 
 
 
 
 
Cash and balances at central banks
88,200 
86,800 
74,200 
Derivatives
171,700 
193,500 
247,000 
Loans and advances
341,500 
346,800 
340,300 
Reverse repos
36,700 
40,000 
41,800 
Other assets
113,700 
115,600 
95,400 
 
 
 
 
Total assets
751,800 
782,700 
798,700 
Derivatives
 
 
 
  - netting and variation margin
(169,500)
(193,400)
(241,700)
  - potential future exposures
54,100 
56,700 
65,300 
Securities financing transactions gross up
2,300 
1,900 
2,300 
Undrawn commitments
52,600 
53,100 
58,600 
Regulatory deductions and other adjustments
200 
800 
100 
 
 
 
 
CRR Leverage exposure
691,500 
701,800 
683,300 
 
 
 
 
CRR leverage ratio%
5.3 
5.1 
5.1 
 
 
 
 
UK leverage exposure (3)
609,400 
618,700 
614,600 
 
 
 
 
UK leverage ratio% (3)
6.0 
5.8 
5.6 
 
Notes:
(1)
CRR as implemented by the PRA in the UK, with effect from 1 January 2014. All regulatory adjustments and deductions to CET1 have been applied in full with the exception of unrealised gains on available-for-sale securities which have been included from 2015 under the PRA transitional basis.
(2)
Based on end-point CRR Tier 1 capital and leverage exposure under the CRR Delegated Act.
(3)
Based on end-point CRR Tier 1 capital and UK leverage exposures reflecting the post EU referendum measures announced by the Bank of England in the third quarter of 2016.
 

 
 
Segment performance
 
Nine months ended 30 September 2017
 
PBB
 
CPB
 
 
 
 
Central
 
 
 
Ulster
 
Commercial
Private
RBS
 
NatWest
Capital
Williams
 items &
Total
 
UK PBB
Bank RoI
 
Banking
Banking
International
 
Markets
Resolution
& Glyn (1)
other (2)
RBS
 
£m
£m
 
£m
£m
£m
 
£m
£m
£m
£m
£m
Income statement
 
 
 
 
 
 
 
 
 
 
 
 
Net interest income
3,359 
310 
 
1,711 
342 
244 
 
65 
100 
499 
146 
6,776 
Other non-interest income
944 
136 
 
967 
145 
48 
 
1,316 
(556)
127 
102 
3,229 
Total income - adjusted (3)
4,303 
446 
 
2,678 
487 
292 
 
1,381 
(456)
626 
248 
10,005 
Own credit adjustments
- 
(3)
 
- 
- 
- 
 
(55)
(20)
- 
- 
(78)
Loss on redemption of own debt
- 
- 
 
- 
- 
- 
 
- 
- 
- 
(7)
(7)
Strategic disposals
- 
- 
 
- 
- 
- 
 
- 
- 
- 
156 
156 
Total income
4,303 
443 
 
2,678 
487 
292 
 
1,326 
(476)
626 
397 
10,076 
Direct expenses - staff costs
(492)
(146)
 
(358)
(110)
(36)
 
(440)
(33)
(141)
(1,239)
(2,995)
                           - other costs
(172)
(41)
 
(166)
(18)
(10)
 
(149)
(38)
(29)
(1,822)
(2,445)
Indirect expenses
(1,448)
(149)
 
(771)
(190)
(93)
 
(355)
(123)
(60)
3,189 
- 
Operating expenses - adjusted (4)
(2,112)
(336)
 
(1,295)
(318)
(139)
 
(944)
(194)
(230)
128 
(5,440)
Restructuring costs - direct
(24)
(25)
 
(42)
(1)
(2)
 
(48)
(195)
- 
(697)
(1,034)
                                 - indirect
(184)
(27)
 
(96)
(16)
(4)
 
(86)
35 
- 
378 
- 
Litigation and conduct costs
(13)
(34)
 
(6)
- 
(8)
 
(47)
(361)
- 
(52)
(521)
Operating expenses
(2,333)
(422)
 
(1,439)
(335)
(153)
 
(1,125)
(715)
(230)
(243)
(6,995)
Operating profit/(loss) before impairment (losses)/releases
1,970 
21 
 
1,239 
152 
139 
 
201 
(1,191)
396 
154 
3,081 
Impairment (losses)/releases
(139)
21 
 
(245)
(4)
(3)
 
(1)
149 
(36)
(1)
(259)
Operating profit/(loss)
1,831 
42 
 
994 
148 
136 
 
200 
(1,042)
360 
153 
2,822 
Operating profit/(loss) - adjusted (3,4)
2,052 
131 
 
1,138 
165 
150 
 
436 
(501)
360 
375 
4,306 
Additional information
 
 
 
 
 
 
 
 
 
 
 
 
Return on equity (5)
30.8%
2.1%
 
8.3%
9.5%
12.2%
 
1.8%
nm
23.0%
nm
5.2%
Return on equity - adjusted (3,4,5)
34.8%
6.5%
 
9.9%
10.8%
13.7%
 
6.1%
nm
23.0%
nm
10.4%
Cost:income ratio (6)
54.2%
95.3%
 
51.8%
68.8%
52.4%
 
84.8%
nm
36.7%
nm
69.1%
Cost:income ratio - adjusted (3,4,6)
49.1%
75.3%
 
46.2%
65.3%
47.6%
 
68.4%
nm
36.7%
nm
53.9%
Average interest earning assets (£bn)
153.0 
25.3 
 
131.2 
18.5 
23.9 
 
17.7 
15.1 
25.3 
nm
419.5 
Net interest margin
2.93%
1.64%
 
1.74%
2.48%
1.37%
 
0.49%
0.88%
2.63%
nm
2.16%
Total assets (£bn)
164.5 
25.1 
 
147.3 
19.9 
24.3 
 
215.7 
89.3 
25.6 
40.1 
751.8 
Funded assets (£bn) (7)
164.5 
25.1 
 
147.3 
19.9 
24.3 
 
112.7 
22.2 
25.6 
38.4 
580.0 
Net loans and advances to customers (£bn)
140.4 
19.5 
 
96.6 
13.3 
9.3 
 
16.7 
8.4 
20.4 
0.1 
324.7 
Risk elements in lending (£bn)
1.7 
3.4 
 
1.7 
0.1 
0.1 
 
-  
1.6 
0.3 
0.1 
9.0 
Impairment provisions (£bn)
(1.1)
(1.1)
 
(0.8)
-  
-  
 
-  
(0.5)
(0.2)
(0.2)
(3.9)
Customer deposits (£bn)
154.0 
17.3 
 
98.2 
27.0 
24.9 
 
7.1 
6.6 
24.6 
0.2 
359.9 
Risk-weighted assets (RWAs) (£bn)
34.0 
17.9 
 
74.6 
9.2 
9.6 
 
31.8 
23.1 
9.3 
1.1 
210.6 
RWA equivalent (£bn) (5)
37.2 
18.9 
 
77.4 
9.2 
9.6 
 
33.5 
25.6 
9.8 
1.3 
222.5 
Employee numbers (FTEs - thousands) (8)
17.4 
2.8 
 
4.9 
1.6 
0.8 
 
5.4 
0.1 
4.0 
36.6 
73.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the notes to this table refer to page 10. nm = not meaningful
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
Segment performance
 
Quarter ended 30 September 2017
 
PBB
 
CPB
 
 
 
 
Central
 
 
 
Ulster
 
Commercial
Private
RBS
 
NatWest
Capital
Williams
 items &
Total
 
UK PBB
Bank RoI
 
Banking
Banking
International
 
Markets
Resolution
& Glyn (1)
other (2)
RBS
 
£m
£m
 
£m
£m
£m
 
£m
£m
£m
£m
£m
Income statement
 
 
 
 
 
 
 
 
 
 
 
 
Net interest income
1,128 
104 
 
570 
116 
83 
 
23 
76 
166 
38 
2,304 
Other non-interest income
420 
46 
 
358 
50 
14 
 
378 
(452)
43 
1 
858 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total income adjusted (3)
1,548 
150 
 
928 
166 
97 
 
401 
(376)
209 
39 
3,162 
Own credit adjustments
- 
- 
 
- 
- 
- 
 
(7)
2 
- 
- 
(5)
Total income
1,548 
150 
 
928 
166 
97 
 
394 
(374)
209 
39 
3,157 
Direct expenses - staff costs
(163)
(50)
 
(113)
(36)
(13)
 
(143)
(7)
(45)
(384)
(954)
                           - other costs
(51)
(17)
 
(55)
(6)
(3)
 
(50)
(19)
(9)
(610)
(820)
Indirect expenses
(485)
(52)
 
(252)
(58)
(33)
 
(113)
(35)
(18)
1,046 
- 
Operating expenses - adjusted (4)
(699)
(119)
 
(420)
(100)
(49)
 
(306)
(61)
(72)
52 
(1,774)
Restructuring costs - direct
(1)
(1)
 
(2)
(1)
(2)
 
(18)
(65)
- 
(154)
(244)
Restructuring costs - indirect
(47)
(8)
 
(19)
(2)
- 
 
(13)
39 
- 
50 
- 
Litigation and conduct costs
- 
(1)
 
(2)
- 
(8)
 
(13)
(89)
- 
(12)
(125)
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating expenses
(747)
(129)
 
(443)
(103)
(59)
 
(350)
(176)
(72)
(64)
(2,143)
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating profit/(loss) before impairment (losses)/releases
801 
21 
 
485 
63 
38 
 
44 
(550)
137 
(25)
1,014 
Impairment (losses)/releases
(67)
10 
 
(151)
3 
2 
 
- 
71 
(11)
- 
(143)
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating profit/(loss)
734 
31 
 
334 
66 
40 
 
44 
(479)
126 
(25)
871 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating profit/(loss) - adjusted (3,4)
782 
41 
 
357 
69 
50 
 
95 
(366)
126 
91 
1,245 
Additional information
 
 
 
 
 
 
 
 
 
 
 
 
Return on equity (5)
36.8%
4.6%
 
8.6%
13.2%
10.4%
 
0.6%
nm
24.6%
nm
4.5%
Return on equity - adjusted (3,4,5)
39.3%
6.1%
 
9.3%
13.8%
13.6%
 
3.6%
nm
24.6%
nm
8.2%
Cost:income ratio (6)
48.3%
86.0%
 
45.7%
62.0%
60.8%
 
88.8%
nm
34.4%
nm
67.5%
Cost:income ratio - adjusted (3,4,6)
45.2%
79.3%
 
43.1%
60.2%
50.5%
 
76.3%
nm
34.4%
nm
55.6%
Average interest earning assets (£bn)
155.8 
26.1 
 
130.0 
19.2 
23.7 
 
19.1 
13.5 
25.4 
nm
431.0 
Net interest margin
2.87%
1.58%
 
1.74%
2.39%
1.39%
 
0.48%
2.23%
2.60%
nm
2.12%
Total assets (£bn)
164.5 
25.1 
 
147.3 
19.9 
24.3 
 
215.7 
89.3 
25.6 
40.1 
751.8 
Funded assets (£bn) (7)
164.5 
25.1 
 
147.3 
19.9 
24.3 
 
112.7 
22.2 
25.6 
38.4 
580.0 
Net loans and advances to customers (£bn)
140.4 
19.5 
 
96.6 
13.3 
9.3 
 
16.7 
8.4 
20.4 
0.1 
324.7 
Risk elements in lending (£bn)
1.7 
3.4 
 
1.7 
0.1 
0.1 
 
- 
1.6 
0.3 
0.1 
9.0 
Impairment provisions (£bn)
(1.1)
(1.1)
 
(0.8)
- 
- 
 
- 
(0.5)
(0.2)
(0.2)
(3.9)
Customer deposits (£bn)
154.0 
17.3 
 
98.2 
27.0 
24.9 
 
7.1 
6.6 
24.6 
0.2 
359.9 
Risk-weighted assets (RWAs) (£bn)
34.0 
17.9 
 
74.6 
9.2 
9.6 
 
31.8 
23.1 
9.3 
1.1 
210.6 
RWA equivalent (£bn) (5)
37.2 
18.9 
 
77.4 
9.2 
9.6 
 
33.5 
25.6 
9.8 
1.3 
222.5 
Employee numbers (FTEs - thousands) (8)
17.4 
2.8 
 
4.9 
1.6 
0.8 
 
5.4 
0.1 
4.0 
36.6 
73.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the notes to this table refer to following page. nm = not meaningful.
 
 
 
 
 
 
 
 
 
 
 
 

 
 
Condensed consolidated income statement for the period ended 30 September 2017 (unaudited)
 
 
 
Nine months ended
 
Quarter ended
 
30 September
30 September
 
30 September
30 June
30 September
2017
2016
 
2017
2017
2016
 
£m
£m
 
£m
£m
£m
 
 
 
 
 
 
 
Interest receivable
8,280 
8,488 
 
2,818 
2,730 
2,796 
Interest payable
(1,504)
(1,988)
 
(514)
(492)
(629)
 
 
 
 
 
 
 
Net interest income (1)
6,776 
6,500 
 
2,304 
2,238 
2,167 
 
 
 
 
 
 
 
Fees and commissions receivable
2,492 
2,519 
 
826 
844 
843 
Fees and commissions payable
(652)
(592)
 
(204)
(231)
(200)
Income from trading activities
832 
384 
 
(52)
485 
401 
(Loss)/gain on redemption of own debt
(7)
(127)
 
- 
(9)
3 
Other operating income
635 
690 
 
283 
380 
96 
 
 
 
 
 
 
 
Non-interest income
3,300 
2,874 
 
853 
1,469 
1,143 
 
 
 
 
 
 
 
Total income
10,076 
9,374 
 
3,157 
3,707 
3,310 
 
 
 
 
 
 
 
Staff costs
(3,576)
(3,982)
 
(1,129)
(1,132)
(1,287)
Premises and equipment
(1,041)
(1,006)
 
(363)
(301)
(354)
Other administrative expenses
(1,736)
(3,234)
 
(528)
(789)
(1,095)
Depreciation and amortisation
(630)
(529)
 
(119)
(169)
(175)
Write down of other intangible assets
(12)
(89)
 
(4)
(8)
- 
 
 
 
 
 
 
 
Operating expenses
(6,995)
(8,840)
 
(2,143)
(2,399)
(2,911)
 
 
 
 
 
 
 
Profit before impairment losses
3,081 
534 
 
1,014 
1,308 
399 
Impairment losses
(259)
(553)
 
(143)
(70)
(144)
 
 
 
 
 
 
 
Operating profit/(loss) before tax
2,822 
(19)
 
871 
1,238 
255 
Tax charge
(992)
(922)
 
(265)
(400)
(582)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Profit/(loss) for the period
1,830 
(941)
 
606 
838 
(327)
 
 
 
 
 
 
 
Attributable to:
 
 
 
 
 
 
Non-controlling interests
21 
37 
 
(8)
18 
7 
Preference share and other dividends
478 
343 
 
222 
140 
135 
Dividend access share
- 
1,193 
 
- 
- 
- 
Ordinary shareholders
1,331 
(2,514)
 
392 
680 
(469)
 
 
 
 
 
 
 
Earnings/(loss) per ordinary share (EPS)
 
 
 
 
 
 
Earnings/(loss) per ordinary share (2)
11.2p
(21.5p)
 
3.3p
5.7p
(3.9p)
 
 
Notes:
(1)
Negative interest on loans and advances is classed as interest payable. Negative interest on customer deposits is classed as interest receivable. Nine months ended and quarter ended 30 September 2016 have been re-presented accordingly.
(2)
There is no dilutive impact in any period.
 
 
 
 
 
 
Notes to segment performance on pages 8 and 9
 (1)
Williams & Glyn refers to the business formerly intended to be divested as a separate legal entity and comprises RBS England and Wales branch-based businesses, along with certain small and medium enterprises and corporate activities across the UK. During the period presented W&G has not operated as a separate legal entity.
(2)
Central items include unallocated transactions which principally comprise volatile items under IFRS and balances in relation to international private banking for Q1 2016.
(3)
Excluding own credit adjustments, (loss)/gain on redemption of own debt and strategic disposals.
(4)
Excluding restructuring costs and litigation and conduct costs.
(5)
RBS’s CET 1 target is 13% but for the purposes of computing segmental return on equity (ROE), to better reflect the differential drivers of capital usage, segmental operating profit after tax and adjusted for preference dividends is divided by average notional equity allocated at different rates of 14% (Ulster Bank RoI - 11% prior to Q1 2017), 11% (Commercial Banking), 14% (Private Banking - 15% prior to Q1 2017), 12% (RBS International) and 15% for all other segments, of the monthly average of segmental risk-weighted assets incorporating the effect of capital deductions (RWAes). RBS’s Return on equity is calculated using profit for the period attributable to ordinary shareholders.
(6)
Operating lease depreciation included in income (nine months ended September 2017 - £107 million and Q3 2017 - £35 million).
(7)
Funded assets exclude derivative assets.
(8)
On 1 January 2017 4.5 thousand employees on a FTE basis were transferred from Central items to NatWest Markets in preparation for ring-fencing.
 
 

 
 
Condensed consolidated statement of comprehensive income for the period ended 30 September 2017 (unaudited)
 
 
 
Nine months ended
 
Quarter ended
 
30 September
30 September
 
30 September
30 June
30 September
 
2017
2016
 
2017
2017
2016
 
£m
£m
 
£m
£m
£m
Profit/(loss) for the period
1,830 
(941)
 
606 
838 
(327)
Items that do not qualify for reclassification
 
 
 
 
 
 
Loss on remeasurement of retirement benefit schemes
(26)
(1,047)
 
 - 
(5)
(52)
Loss on fair value of credit in financial liabilities
 
 
 
 
 
 
  designated at fair value through profit or loss
 
 
 
 
 
 
  due to own credit risk
(107)
- 
 
(30)
(57)
- 
Tax
(5)
285 
 
3 
8 
12 
 
(138)
(762)
 
(27)
(54)
(40)
Items that do qualify for reclassification
 
 
 
 
 
 
Available-for-sale financial assets
37 
(162)
 
8 
(31)
(67)
Cash flow hedges
(983)
1,515 
 
(372)
(422)
(66)
Currency translation
82 
1,276 
 
(21)
109 
205 
Tax
237 
(297)
 
76 
128 
63 
 
(627)
2,332 
 
(309)
(216)
135 
Other comprehensive (loss)/income after tax
(765)
1,570 
 
(336)
(270)
95 
 
 
 
 
 
 
 
Total comprehensive income/(loss) for the period
1,065 
629 
 
270 
568 
(232)
 
 
 
 
 
 
 
Total comprehensive income/(loss) is attributable to:
 
 
 
 
 
 
Non-controlling interests
30 
157 
 
(19)
39 
32 
Preference shareholders
155 
192 
 
70 
45 
79 
Paid-in equity holders
323 
151 
 
152 
95 
56 
Dividend access share
 - 
1,193 
 
 - 
 - 
 - 
Ordinary shareholders
557 
(1,064)
 
67 
389 
(399)
 
1,065 
629 
 
270 
568 
(232)
 

 
 
Condensed consolidated balance sheet as at 30 September 2017 (unaudited)
 
 
 
30 September
30 June
31 December
2017 
2017 
2016 
 
£m
£m 
£m
 
 
 
 
Assets
 
 
 
Cash and balances at central banks
88,210 
86,807 
74,250 
Net loans and advances to banks
16,671 
20,685 
17,278 
Reverse repurchase agreements and stock borrowing
12,905 
14,847 
12,860 
Loans and advances to banks
29,576 
35,532 
30,138 
Net loans and advances to customers
324,650 
326,059 
323,023 
Reverse repurchase agreements and stock borrowing
23,767 
25,183 
28,927 
Loans and advances to customers
348,417 
351,242 
351,950 
Debt securities
87,860 
86,169 
72,522 
Equity shares
507 
518 
703 
Settlement balances
8,528 
12,091 
5,526 
Derivatives
171,720 
193,531 
246,981 
Intangible assets
6,484 
6,467 
6,480 
Property, plant and equipment
4,777 
4,823 
4,590 
Deferred tax
1,637 
1,677 
1,803 
Prepayments, accrued income and other assets
4,046 
3,797 
3,713 
Total assets
751,762 
782,654 
798,656 
 
 
 
 
Liabilities
 
 
 
Bank deposits
36,186 
38,965 
33,317 
Repurchase agreements and stock lending
7,047 
5,183 
5,239 
Deposits by banks
43,233 
44,148 
38,556 
Customer deposits
359,879 
359,882 
353,872 
Repurchase agreements and stock lending
33,245 
37,855 
27,096 
Customer accounts
393,124 
397,737 
380,968 
Debt securities in issue
31,700 
31,997 
27,245 
Settlement balances
9,094 
11,379 
3,645 
Short positions
31,793 
29,862 
22,077 
Derivatives
164,394 
184,161 
236,475 
Provisions for liabilities and charges
7,109 
11,227 
12,836 
Accruals and other liabilities
6,925 
6,603 
7,006 
Retirement benefit liabilities
152 
182 
363 
Deferred tax
516 
585 
662 
Subordinated liabilities
14,248 
14,724 
19,419 
 
 
 
 
Total liabilities
702,288 
732,605 
749,252 
 
 
 
 
Equity
 
 
 
Non-controlling interests
746 
844 
795 
Owners’ equity*
 
 
 
  Called up share capital
11,906 
11,876 
11,823 
  Reserves
36,822 
37,329 
36,786 
 
 
 
 
Total equity
49,474 
50,049 
49,404 
 
 
 
 
Total liabilities and equity
751,762 
782,654 
798,656 
 
 
 
 
*Owners’ equity attributable to:
 
 
 
Ordinary shareholders
42,105 
42,149 
41,462 
Other equity owners
6,623 
7,056 
7,147 
 
 
 
 
 
48,728 
49,205 
48,609 
 

 
 
Condensed consolidated statement of changes in equity for the period ended 30 September 2017 (unaudited)
 
 
 
Share
 
 
 
 
 
 
 
capital and
 
 
 
Total
Non
 
 
statutory
Paid-in
Retained
Other
owners'
controlling
Total
 
reserves
equity
earnings
reserves*
equity
 interests
equity
 
£m
£m
£m
£m
£m
£m
£m
At 1 January 2017
41,926 
4,582 
(12,936)
15,037 
48,609 
795 
49,404 
Profit attributable to ordinary shareholders
 
 
 
 
 
 
 
  and other equity owners
- 
- 
1,809 
- 
1,809 
21 
1,830 
Other comprehensive income
 
 
 
 
 
 
 
 - changes in fair value of credit in financial
 
 
 
 
 
 
 
   liabilities designated at fair value through profit
 
 
 
 
 
 
 
   or loss due to own credit risk
- 
- 
(107)
- 
(107)
- 
(107)
 - other amounts recognised in equity
- 
- 
(26)
(175)
(201)
9 
(192)
 - amounts transferred from equity to profit or loss
- 
- 
- 
(677)
(677)
- 
(677)
 - recycled to profit or loss on disposal
 
 
 
 
 
 
 
   of businesses (1)
- 
- 
- 
(21)
(21)
- 
(21)
 - tax
- 
- 
(5)
237 
232 
- 
232 
Preference share and other dividends paid
- 
- 
(478)
- 
(478)
(20)
(498)
Shares and securities issued during the period
226 
- 
(5)
- 
221 
- 
221 
Redemption of preference shares (2)
692 
- 
(692)
- 
-
- 
-
Reclassification of paid-in equity (3)
- 
(524)
(196)
- 
(720)
- 
(720)
Capital reduction (4)
(30,331)
- 
30,331 
- 
-
- 
-
Share-based payments - gross
- 
- 
(26)
- 
(26)
- 
(26)
Movement in own shares held
87 
- 
- 
- 
87 
- 
87 
Equity withdrawn
- 
- 
- 
- 
- 
(59)
(59)
At 30 September 2017
12,600 
4,058 
17,669 
14,401 
48,728 
746 
49,474 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
30 September
 
 
 
 
 
 
 
2017
Total equity is attributable to:
 
 
 
 
£m
Non-controlling interests
 
 
 
 
 
 
746 
Preference shareholders
 
 
 
 
 
 
2,565 
Paid-in equity holders
 
 
 
 
 
 
4,058 
Ordinary shareholders
 
 
 
 
 
 
42,105 
 
 
 
 
 
 
 
49,474 
*Other reserves consist of:
 
 
 
 
 
 
Merger reserve
 
 
 
 
 
 
10,881 
Available-for-sale reserve
 
 
 
 
 
 
260 
Cash flow hedging reserve
 
 
 
 
 
 
298 
Foreign exchange reserve
 
 
 
 
 
 
2,962 
 
 
 
 
 
 
 
14,401 
 
 
Notes:
(1)
No tax impact.
(2)
In September 2017, non-cumulative US dollar preference shares recorded as debt were redeemed at their original issue price of US$1.1billion. The nominal value of £0.3 million has been credited to the capital redemption reserve; share premium increased by £0.7 billion in respect of the premium received on issue, with a corresponding decrease in retained earnings.
(3)
Paid-in equity reclassified to liabilities as a result of the call of RBS Capital Trust D in March 2017 (redeemed in June 2017) and the call of US$564 million and CAD321 million EMTN notes in August 2017 (redeemed in October 2017).
(4)
On 15 June 2017, the Court of Session approved a reduction of RBSG plc capital so that the amounts which stood to the credit of share premium account and capital redemption reserve were transferred to retained earnings.
 
 
 

 
 
Notes
 
1. Basis of preparation
The condensed consolidated financial statements should be read in conjunction with RBS’s 2016 Annual Report and Accounts which were prepared in accordance with International Financial Reporting Standards issued by the International Accounting Standards Board (IASB) and interpretations issued by the IFRS Interpretations Committee of the IASB as adopted by the European Union (EU) (together IFRS).
 
Accounting policies
Ahead of adopting IFRS 9 Financial Instruments from 1 January 2018 RBS has adopted the provisions in respect of the presentation of gains and losses on financial liabilities designated as at fair value through profit or loss from 1 January 2017.  Accordingly, a loss of £30 million has been reported in the consolidated statement of other comprehensive income in Q3 2017 instead of in the consolidated income statement. Comparatives have not been restated, however, in Q3 2016 a loss of £92 million was included in the consolidated income statement. Own credit adjustments on financial liabilities held-for-trading will continue to be recognised in the consolidated income statement, a loss of £5 million was reported in Q3 2017 (Q3 2016 – loss of £64 million).
 
Apart from the above RBS’s principal accounting policies are as set out on pages 297 to 306 of the 2016 Annual Report and Accounts. Other amendments to IFRS effective for 2017 have not had a material effect on RBS’s Q3 2017 results.
 
Critical accounting policies and key sources of estimation uncertainty
The judgements and assumptions that are considered to be the most important to the portrayal of RBS’s financial condition are those relating to goodwill, provisions for liabilities, deferred tax, loan impairment provisions and fair value of financial instruments. These critical accounting policies and judgements are described on pages 306 to 308 of RBS’s 2016 Annual Report and Accounts.
 
Going concern
Having reviewed RBS’s forecasts, projections and other relevant evidence, the directors have a reasonable expectation that RBS will continue in operational existence for the foreseeable future. Accordingly, the results for the period ended 30 September 2017 have been prepared on a going concern basis.
 
 
2. Provisions for liabilities and charges
 
 
 
Payment
Other
Residential
Litigation
 
 
 
protection
 customer
mortgage
and other
 
 
 
insurance
 redress (1)
backed securities
regulatory
Other (2)
Total
 
£m
£m
£m
£m
£m
£m
 
 
 
 
 
 
 
At 1 January 2017
1,253 
1,105 
6,752 
1,918 
1,808 
12,836 
Currency translation and other movements
- 
(1)
(114)
(13)
10 
(118)
Charge to income statement
- 
- 
- 
32 
204 
236 
Releases to income statement
- 
(2)
- 
(3)
(39)
(44)
Provisions utilised
(78)
(99)
- 
(950)
(164)
(1,291)
At 31 March 2017
1,175 
1,003 
6,638 
984 
1,819 
11,619 
 
 
 
 
 
 
 
Currency translation and other movements
- 
5 
(237)
(17)
38 
(211)
Charge to income statement
- 
55 
222 
59 
371 
707 
Releases to income statement
- 
(38)
- 
(4)
(96)
(138)
Provisions utilised
(81)
(114)
(44)
(113)
(398)
(750)
At 30 June 2017
1,094 
911 
6,579 
909 
1,734 
11,227 
 
 
 
 
 
 
 
Currency translation and other movements
- 
1 
(159)
(4)
(14)
(176)
Charge to income statement
- 
1 
- 
105 
118 
224 
Releases to income statement
- 
(1)
- 
(2)
(1)
(4)
Provisions utilised (3)
(115)
(84)
(3,588)
(221)
(154)
(4,162)
At 30 September 2017
979 
828 
2,832 
787 
1,683 
7,109 
 
Notes:
(1)
Closing provision predominantly relates to investment advice, packaged accounts (including costs) and tracker mortgages.
(2)
The Group recognised a £750 million provision in 2016 as a consequence of the announcement that HM Treasury is seeking a revised package of remedies that would conclude its remaining State Aid commitments. An additional charge of £50 million was taken in Q2 2017 following further revisions to the package, taking the total provision to £800 million.
(3)
Q3 2017 utilisation includes the $4.75 billion payment made following the settlement reached between RBS and the Federal Housing Finance Agency in relation to RBS’s issuance and underwriting of RMBS in the US.
 
 
There are uncertainties as to the eventual cost of redress in relation to certain of the provisions contained in the table above. Assumptions relating to these are inherently uncertain and the ultimate financial impact may be different from the amount provided.
 

 
 
Notes
 
3. Material developments in litigation, investigations and reviews
RBS’s 2017 Interim Results issued on 4 August 2017 included comprehensive disclosures about RBS’s litigation, investigations and reviews in Note 12. Set out below are the material developments in these matters since the 2017 Interim Results were published. RBS generally does not disclose information about the establishment or existence of a provision for a particular matter where disclosure of the information can be expected to prejudice seriously RBS’s position in the matter.
 
Litigation
Residential mortgage-backed securities (RMBS) litigation in the US
Among other RMBS litigation, RBS Securities Inc. (RBSSI) remains a defendant in a lawsuit relating to RMBS issued by Nomura Holding America Inc. (Nomura) and subsidiaries, filed by the US Federal Housing Finance Agency (FHFA) as conservator for the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac). On 11 May 2015, following a trial, the United States District Court for the Southern District of New York issued a written decision in favour of FHFA, finding, as relevant to RBS, that the offering documents for four Nomura-issued RMBS for which RBSSI served as an underwriter contained materially misleading statements about the mortgage loans that backed the securitisations. Nomura and RBS appealed. On 28 September 2017, the court’s judgment against Nomura and RBSSI was affirmed by the United States Court of Appeals for the Second Circuit.
 
RBSSI estimates that its net exposure under the court’s judgment is approximately US$383 million, which consists of the difference between the amount of the judgment against RBSSI (US$636 million) and the estimated market value of the four RMBS that FHFA would return to RBSSI pursuant to the judgment, plus the costs and attorney’s fees that will be due to FHFA if the judgment is upheld. The estimated net exposure in this matter is covered by an existing provision. The judgment is stayed pending potential further appeal by the defendants, though post-judgment interest on the judgment amount will accrue while the appeal is pending. RBSSI intends to pursue a contractual claim for indemnification against Nomura with respect to any losses it suffers as a result of this matter.
 
RBS continues to caution that, in connection with its RMBS litigation matters and RMBS investigations taken as a whole, further substantial provisions and costs may be recognised and, depending upon the final outcomes, other adverse consequences may occur.
 
London Interbank Offered Rate (LIBOR)
As previously disclosed, certain members of the Group have been named as defendants in a number of class actions and individual claims filed in the US with respect to the setting of LIBOR and certain other benchmark interest rates. On 18 August 2017, the court in the action relating to the Singapore Interbank Offered Rate and Singapore Swap Offer Rate dismissed all claims against RBS for lack of personal jurisdiction; however, the court is allowing the plaintiffs to replead their complaint. On 25 September 2017, the court in the action relating to Swiss Franc LIBOR dismissed all claims against all defendants; however, the court is allowing the plaintiffs to replead their complaint. Both of these actions are pending in the United States District Court for the Southern District of New York.
 
FX antitrust litigation
On 3 August 2017, the United States District Court for the Southern District of New York held that the amended complaint in the FX-related antitrust class action on behalf of a purported class of “consumers and end-user businesses” adequately pleads that the class has the requisite antitrust standing. As a result, the discovery phase has commenced. RBS and the other defendants are seeking reconsideration of the court’s decision regarding standing or, in the alternative, permission to take an immediate appeal to the United States Court of Appeals for the Second Circuit.
 
Notes
 
3. Material developments in litigation, investigations and reviews (continued)
 
Weiss v. National Westminster Bank Plc (NatWest)
As previously disclosed, NatWest is defending a lawsuit filed by a number of US nationals (or their estates, survivors, or heirs) who were victims of terrorist attacks in Israel. The plaintiffs allege that NatWest is liable for damages arising from those attacks pursuant to the US Anti-terrorism Act because NatWest previously maintained bank accounts and transferred funds for the Palestine Relief & Development Fund, an organisation which plaintiffs allege solicited funds for Hamas, the alleged perpetrator of the attacks. On 5 October 2017, the United States District Court for the Eastern District of New York dismissed claims against NatWest with respect to two terrorist attacks, but denied NatWest’s summary judgment motion with respect to claims arising from 16 other attacks. No trial date has been set.
 
Investigations and reviews
RMBS and other securitised products investigations
On 26 October 2017, the United States Attorney for the District of Connecticut (USAO) announced that it entered into a Non-Prosecution Agreement (NPA) with RBSSI in connection with misrepresentations to counterparties relating to secondary trading in various forms of asset-backed securities.  The NPA, which recognises RBSSI’s timely self-reporting and cooperation, requires RBSSI to pay a penalty of US$35 million, reimburse customers at least US$9.1 million, and continue to cooperate with the investigation.  These amounts are covered by existing provisions.  As part of the NPA, the USAO has agreed not to file criminal charges against RBSSI relating to certain conduct and information described in the NPA if RBSSI complies with the NPA during its one-year term.  In March and December 2015, two former RBSSI traders entered guilty pleas in the United States District Court for the District of Connecticut, each to one count of conspiracy to commit securities fraud while employed at RBSSI.
 
FCA review of RBS’s treatment of SMEs
On 23 October 2017, the FCA published an interim account incorporating a summary of the Skilled Person’s report which stated that, further to the general investigation announced in November 2016, the FCA has decided to carry out a more focused investigation. 
 
 
4. Post balance sheet events
Other than matters disclosed, there have been no further significant events between 30 September 2017 and the date of approval of this announcement.
 

 
 
Forward-looking statements
 
Cautionary statement regarding forward-looking statements
Certain sections in this document contain ‘forward-looking statements’ as that term is defined in the United States Private Securities Litigation Reform Act of 1995, such as statements that include the words ‘expect’, ‘estimate’, ‘project’, ‘anticipate’, ‘commit’, ‘believe’, ‘should’, ‘intend’, ‘plan’, ‘could’, ‘probability’, ‘risk’, ‘Value-at-Risk (VaR)’, ‘target’, ‘goal’, ‘objective’, ‘may’, ‘endeavour’, ‘outlook’, ‘optimistic’, ‘prospects’ and similar expressions or variations on these expressions.
 
In particular, this document includes forward-looking statements relating, but not limited to: future profitability and performance, including financial performance targets such as return on tangible equity; cost savings and targets, including cost:income ratios; litigation and government and regulatory investigations, including the timing and financial and other impacts thereof; structural reform and the implementation of the UK ring-fencing regime; the implementation of RBS’s transformation programme, including the further restructuring of the NatWest Markets business; the satisfaction of the Group’s residual EU State Aid obligations; the continuation of RBS’s balance sheet reduction programme, including the reduction of risk-weighted assets (RWAs) and the timing thereof; capital and strategic plans and targets; capital, liquidity and leverage ratios and requirements, including CET1 Ratio, RWA equivalents (RWAe), Pillar 2 and other regulatory buffer requirements, minimum requirement for own funds and eligible liabilities, and other funding plans; funding and credit risk profile; capitalisation; portfolios; net interest margin; customer loan and income growth; the level and extent of future impairments and write-downs, including with respect to goodwill; restructuring and remediation costs and charges; future pension contributions; RBS’s exposure to political risks, operational risk, conduct risk, cyber and IT risk and credit rating risk and to various types of market risks, including as interest rate risk, foreign exchange rate risk and commodity and equity price risk; customer experience including our Net Promotor Score (NPS); employee engagement and gender balance in leadership positions.
 
Limitations inherent to forward-looking statements
These statements are based on current plans, estimates, targets and projections, and are subject to significant inherent risks, uncertainties and other factors, both external and relating to the Group’s strategy or operations, which may result in the Group being unable to achieve the current targets, predictions, expectations and other anticipated outcomes expressed or implied by such forward-looking statements. In addition certain of these disclosures are dependent on choices relying on key model characteristics and assumptions and are subject to various limitations, including assumptions and estimates made by management. By their nature, certain of these disclosures are only estimates and, as a result, actual future gains and losses could differ materially from those that have been estimated. Accordingly, undue reliance should not be placed on these statements. Forward-looking statements speak only as of the date we make them and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
 
Important factors that could affect the actual outcome of the forward-looking statements
We caution you that a large number of important factors could adversely affect our results or our ability to implement our strategy, cause us to fail to meet our targets, predictions, expectations and other anticipated outcomes or affect the accuracy of forward-looking statements we describe in this document, including in the risk factors and other uncertainties set out in the Group’s 2016 Annual Report on Form 20-F and other materials filed with, or furnished to, the US Securities and Exchange Commission, and other risk factors and uncertainties discussed in this document. These include the significant risks for RBS presented by the outcomes of the legal, regulatory and governmental actions and investigations that RBS is or may be subject to (including active civil and criminal investigations) and any resulting material adverse effect on RBS of unfavourable outcomes and the timing thereof (including where resolved by settlement); economic, regulatory and political risks, including as may result from the uncertainty arising from the vote to leave in the EU Referendum and from the outcome of general elections in the UK and changes in government policies; RBS’s ability to satisfy its residual EU State Aid obligations and the timing thereof; RBS’s ability to successfully implement the significant and complex restructuring required to be undertaken in order to implement the UK ring-fencing regime and related costs; RBS’s ability to successfully implement the various initiatives that are comprised in its transformation programme, particularly the proposed further restructuring of the NatWest Markets business, the balance sheet reduction programme and its significant cost-saving initiatives and whether RBS will be a viable, competitive, customer focused and profitable bank especially after its restructuring and the implementation of the UK ring-fencing regime; the exposure of RBS to cyber-attacks and its ability to defend against such attacks; RBS’s ability to achieve its capital and leverage requirements or targets which will depend in part on RBS’s success in reducing the size of its business and future profitability as well as developments which may impact its CET1 capital including additional litigation or conduct costs, additional pension contributions, further impairments or accounting changes; ineffective management of capital or changes to regulatory requirements relating to capital adequacy and liquidity or failure to pass mandatory stress tests; RBS’s ability to access sufficient sources of capital, liquidity and funding when required; changes in the credit ratings of RBS, RBS entities or the UK government; declining revenues resulting from lower customer retention and revenue generation in light of RBS’s strategic refocus on the UK; as well as increasing competition from new incumbents and disruptive technologies.
 
 

 
 
Forward-looking statements
 
In addition, there are other risks and uncertainties that could adversely affect our results, ability to implement our strategy, cause us to fail to meet our targets or the accuracy of forward-looking statements in this document. These include operational risks that are inherent to RBS’s business and will increase as a result of RBS’s significant restructuring initiatives being concurrently implemented; the potential negative impact on RBS’s business of global economic and financial market conditions and other global risks, including risks arising out of geopolitical events and political developments; the impact of a prolonged period of low interest rates or unanticipated turbulence in interest rates, yield curves, foreign currency exchange rates, credit spreads, bond prices, commodity prices, equity prices; basis, volatility and correlation risks; the extent of future write-downs and impairment charges caused by depressed asset valuations; deteriorations in borrower and counterparty credit quality; heightened regulatory and governmental scrutiny and the increasingly regulated environment in which RBS operates as well as divergences in regulatory requirements in the jurisdictions in which RBS operates; the risks relating to RBS’s IT systems or a failure to protect itself and its customers against cyber threats, reputational risks; risks relating to increased pension liabilities and the impact of pension risk on RBS’s capital position; risks relating to the failure to embed and maintain a robust conduct and risk culture across the organisation or if its risk management framework is ineffective; RBS’s ability to attract and retain qualified personnel; limitations on, or additional requirements imposed on, RBS’s activities as a result of HM Treasury’s investment in RBS; the value and effectiveness of any credit protection purchased by RBS; risks relating to the reliance on valuation, capital and stress test models and any inaccuracies resulting therefrom or failure to accurately reflect changes in the micro and macroeconomic environment in which RBS operates, risks relating to changes in applicable accounting policies or rules which may impact the preparation of RBS’s financial statements or adversely impact its capital position; the impact of the recovery and resolution framework and other prudential rules to which RBS is subject; the recoverability of deferred tax assets by the Group; and the success of RBS in managing the risks involved in the foregoing.
 
The forward-looking statements contained in this document speak only as at the date hereof, and RBS does not assume or undertake any obligation or responsibility to update any forward-looking statement to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
 
The information, statements and opinions contained in this document do not constitute a public offer under any applicable legislation or an offer to sell or solicit of any offer to buy any securities or financial instruments or any advice or recommendation with respect to such securities or other financial instruments.
 
 

 
 
 
 
Additional information
 
Presentation of information
In this document, ‘RBSG plc’ or the ‘parent company’ refers to The Royal Bank of Scotland Group plc, and ‘RBS’ or the ‘Group’ refers to RBSG plc and its subsidiaries.
 
Financial information contained in this document does not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006 (‘the Act’). The statutory accounts for the year ended 31 December 2016 have been filed with the Registrar of Companies. The report of the auditor on those statutory accounts was unqualified, did not draw attention to any matters by way of emphasis and did not contain a statement under section 498(2) or (3) of the Act.
 
In this document Williams & Glyn refers to the business formerly intended to be divested as a separate legal entity, which continues to be reported as a separate operating segment. 
 
Key operating indicators
As described in Note 1 on page 14, RBS prepares its financial statements in accordance with IFRS as issued by the IASB which constitutes a body of generally accepted accounting principles (GAAP). This document contains a number of adjusted or alternative performance measures, also known as non-GAAP financial measures. These measures exclude certain items which management believe are not representative of the underlying performance of the business and which distort period-on-period comparison. These measures include:
●
‘Adjusted’ measures of financial performance, principally operating performance before: own credit adjustments; gain or loss on redemption of own debt; strategic disposals; restructuring costs and litigation and conduct costs;
●
Performance, funding and credit metrics such as ‘return on tangible equity’, ‘adjusted return on tangible equity’ and related RWA equivalents incorporating the effect of capital deductions (RWAes), total assets excluding derivatives (funded assets), net interest margin (NIM) adjusted for items designated at fair value through profit or loss (non-statutory NIM), cost:income ratio, loan:deposit ratio and REIL/impairment provision ratios. These are internal metrics used to measure business performance;
●
Personal & Business Banking (PBB) franchise results, combining the reportable segments of UK Personal & Business Banking (UK PBB) and Ulster Bank RoI, Commercial & Private Banking (CPB) franchise results, combining the reportable segments of Commercial Banking, Private Banking and RBS International (RBSI) and ‘core businesses’ results combining PBB, CPB and NatWest Markets results which are presented to provide investors with a summary of the Group’s business performance; and
●
Cost savings progress and 2017 target calculated using operating expenses excluding litigation and conduct costs, restructuring costs and the VAT recoveries.
 
 
Contacts
Analyst enquiries:
Matt Waymark
Investor Relations
+44 (0) 207 672 1758
Media enquiries:
RBS Press Office
 
+44 (0) 131 523 4205
 
 
Analyst and investor presentation
Web cast and dial in details
Date:
Friday 27 October 2017
www.rbs.com/results
Time:
9:00 am UK time
International – +44 1452 568 172
Conference ID:
59366016
UK Free Call – 0800 694 8082
US Toll Free – 1 866 966 8024
 
Available on www.rbs.com/results
●
Interim Management Statement Q3 2017 and background slides.
●
A financial supplement containing income statement, balance sheet and segment performance information for the nine quarters ended 30 September 2017.
●
Pillar 3 supplement at 30 September 2017.
 

 
 
 
 
 
 
 
 
 
 
Appendix
 
Segmental income statement reconciliations
 
 
 
 
Segmental income statement reconciliations
 
PBB
 
CPB
 
 
 
 
Central
 
 
 
Ulster
 
Commercial
Private
RBS
 
NatWest
Capital
Williams
 items &
Total
 
UK PBB
Bank RoI
 
Banking
Banking
International
 
Markets
Resolution
& Glyn
other
RBS
Nine months ended 30 September 2017
£m
£m
 
£m
£m
£m
 
£m
£m
£m
£m
£m
Income statement
 
 
 
 
 
 
 
 
 
 
 
 
Total income - statutory
4,303 
443 
 
2,678 
487 
292 
 
1,326 
(476)
626 
397 
10,076 
Own credit adjustments
- 
3 
 
- 
- 
- 
 
55 
20 
- 
- 
78 
Loss on redemption of own debt
- 
- 
 
- 
- 
- 
 
- 
- 
- 
7 
7 
Strategic disposals
- 
- 
 
- 
- 
- 
 
- 
- 
- 
(156)
(156)
Total income - adjusted
4,303 
446 
 
2,678 
487 
292 
 
1,381 
(456)
626 
248 
10,005 
Operating expenses - statutory
(2,333)
(422)
 
(1,439)
(335)
(153)
 
(1,125)
(715)
(230)
(243)
(6,995)
Restructuring costs - direct
24 
25 
 
42 
1 
2 
 
48 
195 
- 
697 
1,034 
Restructuring costs - indirect
184 
27 
 
96 
16 
4 
 
86 
(35)
- 
(378)
- 
Litigation and conduct costs
13 
34 
 
6 
- 
8 
 
47 
361 
- 
52 
521 
Operating expenses - adjusted
(2,112)
(336)
 
(1,295)
(318)
(139)
 
(944)
(194)
(230)
128 
(5,440)
Impairment (losses)/releases
(139)
21 
 
(245)
(4)
(3)
 
(1)
149 
(36)
(1)
(259)
Operating profit/(loss) - statutory
1,831 
42 
 
994 
148 
136 
 
200 
(1,042)
360 
153 
2,822 
Operating profit/(loss) - adjusted
2,052 
131 
 
1,138 
165 
150 
 
436 
(501)
360 
375 
4,306 
Additional information
 
 
 
 
 
 
 
 
 
 
 
 
Return on equity (1)
30.8%
2.1%
 
8.3%
9.5%
12.2%
 
1.8%
nm
23.0%
nm
5.2%
Return on equity   - adjusted (1,2,3)
34.8%
6.5%
 
9.9%
10.8%
13.7%
 
6.1%
nm
23.0%
nm
10.4%
Cost:income ratio (4)
54.2%
95.3%
 
51.8%
68.8%
52.4%
 
84.8%
nm
36.7%
nm
69.1%
Cost:income ratio - adjusted (2,3,4)
49.1%
75.3%
 
46.2%
65.3%
47.6%
 
68.4%
nm
36.7%
nm
53.9%
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine months ended 30 September 2016
 
 
 
 
 
 
 
 
 
 
 
 
Income statement
 
 
 
 
 
 
 
 
 
 
 
 
Total income - statutory
3,951 
439 
 
2,548 
496 
278 
 
1,289 
(69)
620 
(178)
9,374 
Own credit adjustments
- 
(3)
 
- 
- 
- 
 
(82)
(142)
- 
(67)
(294)
Loss on redemption of own debt
- 
- 
 
- 
- 
- 
 
- 
- 
- 
127 
127 
Strategic disposals
- 
- 
 
- 
- 
- 
 
- 
81 
- 
(245)
(164)
Total income - adjusted
3,951 
436 
 
2,548 
496 
278 
 
1,207 
(130)
620 
(363)
9,043 
Operating expenses - statutory
(2,784)
(443)
 
(1,458)
(390)
(110)
 
(1,110)
(915)
(353)
(1,277)
(8,840)
Restructuring costs - direct
50 
32 
 
13 
1 
1 
 
16 
35 
57 
894 
1,099 
Restructuring costs - indirect
86 
4 
 
49 
22 
2 
 
50 
35 
- 
(248)
- 
Litigation and conduct costs
420 
95 
 
16 
2 
(1)
 
62 
257 
- 
889 
1,740 
Operating expenses - adjusted
(2,228)
(312)
 
(1,380)
(365)
(108)
 
(982)
(588)
(296)
258 
(6,001)
Impairment (losses)/releases
(67)
66 
 
(123)
(5)
(11)
 
- 
(383)
(31)
1 
(553)
Operating profit/(loss) - statutory
1,100 
62 
 
967 
101 
157 
 
179 
(1,367)
236 
(1,454)
(19)
Operating profit/(loss) - adjusted
1,656 
190 
 
1,045 
126 
159 
 
225 
(1,101)
293 
(104)
2,489 
Additional information
 
 
 
 
 
 
 
 
 
 
 
 
Return on equity (1)
17.0%
3.1%
 
8.5%
7.0%
15.4%
 
1.6%
nm
14.8%
nm
(8.5%)
Return on equity  - adjusted (1,2,3)
26.4%
9.5%
 
9.4%
8.9%
15.6%
 
2.4%
nm
18.3%
nm
(0.6%)
Cost:income ratio (4)
70.5%
100.9%
 
55.4%
78.6%
39.6%
 
86.1%
nm
56.9%
nm
94.2%
Cost:income ratio - adjusted (2,3,4)
56.4%
71.6%
 
52.2%
73.6%
38.8%
 
81.4%
nm
47.7%
nm
65.9%
 
 
 
 
 
 
 
 
 
 
 
 
 
For notes refer to page 3 of this appendix.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Segmental income statement reconciliations
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PBB
 
CPB
 
 
 
 
Central
 
 
 
Ulster
 
Commercial
Private
RBS
 
NatWest
Capital
Williams
 items &
Total
 
UK PBB
Bank RoI
 
Banking
Banking
International
 
Markets
Resolution
& Glyn
other
RBS
Quarter ended 30 September 2017
£m
£m
 
£m
£m
£m
 
£m
£m
£m
£m
£m
Income statement
 
 
 
 
 
 
 
 
 
 
 
 
Total income - statutory
1,548 
150 
 
928 
166 
97 
 
394 
(374)
209 
39 
3,157 
Own credit adjustments
- 
- 
 
- 
- 
- 
 
7 
(2)
- 
- 
5 
Total income - adjusted
1,548 
150 
 
928 
166 
97 
 
401 
(376)
209 
39 
3,162 
Operating expenses - statutory
(747)
(129)
 
(443)
(103)
(59)
 
(350)
(176)
(72)
(64)
(2,143)
Restructuring costs - direct
1 
1 
 
2 
1 
2 
 
18 
65 
- 
154 
244 
Restructuring costs - indirect
47 
8 
 
19 
2 
- 
 
13 
(39)
- 
(50)
- 
Litigation and conduct costs
- 
1 
 
2 
- 
8 
 
13 
89 
- 
12 
125 
Operating expenses - adjusted
(699)
(119)
 
(420)
(100)
(49)
 
(306)
(61)
(72)
52 
(1,774)
Impairment (losses)/releases
(67)
10 
 
(151)
3 
2 
 
- 
71 
(11)
- 
(143)
Operating profit/(loss) - statutory
734 
31 
 
334 
66 
40 
 
44 
(479)
126 
(25)
871 
Operating profit/(loss) - adjusted
782 
41 
 
357 
69 
50 
 
95 
(366)
126 
91 
1,245 
Additional information
 
 
 
 
 
 
 
 
 
 
 
 
Return on equity (1)
36.8%
4.6%
 
8.6%
13.2%
10.4%
 
0.6%
nm
24.6%
nm
4.5%
Return on equity - adjusted (1,2,3)
39.3%
6.1%
 
9.3%
13.8%
13.6%
 
3.6%
nm
24.6%
nm
8.2%
Cost:income ratio (4)
48.3%
86.0%
 
45.7%
62.0%
60.8%
 
88.8%
nm
34.4%
nm
67.5%
Cost:income ratio - adjusted (2,3,4)
45.2%
79.3%
 
43.1%
60.2%
50.5%
 
76.3%
nm
34.4%
nm
55.6%
 
 
 
 
 
 
 
 
 
 
 
 
 
Quarter ended 30 June 2017
 
 
 
 
 
 
 
 
 
 
 
 
Income statement
 
 
 
 
 
 
 
 
 
 
 
 
Total income - statutory
1,378 
148 
 
885 
161 
97 
 
444 
(43)
211 
426 
3,707 
Own credit adjustments
- 
2 
 
- 
- 
- 
 
28 
15 
- 
(1)
44 
Gain on redemption of own debt
- 
- 
 
- 
- 
- 
 
- 
- 
- 
9 
9 
Strategic disposals
- 
- 
 
- 
- 
- 
 
- 
- 
- 
(156)
(156)
Total income - adjusted
1,378 
150 
 
885 
161 
97 
 
472 
(28)
211 
278 
3,604 
Operating expenses - statutory
(735)
(151)
 
(446)
(108)
(48)
 
(355)
(378)
(74)
(104)
(2,399)
Restructuring costs - direct
3 
5 
 
1 
- 
- 
 
10 
60 
- 
134 
213 
Restructuring costs - indirect
26 
4 
 
17 
3 
1 
 
25 
(12)
- 
(64)
- 
Litigation and conduct costs
9 
33 
 
1 
- 
- 
 
3 
266 
- 
30 
342 
Operating expenses - adjusted
(697)
(109)
 
(427)
(105)
(47)
 
(317)
(64)
(74)
(4)
(1,844)
Impairment (losses)/releases
(40)
(13)
 
(33)
(4)
2 
 
(1)
33 
(14)
- 
(70)
Operating profit/(loss) - statutory
603 
(16)
 
406 
49 
51 
 
88 
(388)
123 
322 
1,238 
Operating profit/(loss) - adjusted
641 
28 
 
425 
52 
52 
 
154 
(59)
123 
274 
1,690 
Additional information
 
 
 
 
 
 
 
 
 
 
 
 
Return on equity (1)
30.8%
(2.4%)
 
10.7%
9.6%
14.0%
 
2.9%
nm
23.5%
nm
8.0%
Return on equity - adjusted (1,2,3)
32.8%
4.3%
 
11.4%
10.3%
14.3%
 
6.6%
nm
23.5%
nm
12.9%
Cost:income ratio (4)
53.3%
102.0%
 
48.3%
67.1%
49.5%
 
80.0%
nm
35.1%
nm
64.4%
Cost:income ratio - adjusted (2,3,4)
50.6%
72.7%
 
46.1%
65.2%
48.5%
 
67.2%
nm
35.1%
nm
50.7%
 
 
 
 
 
 
 
 
 
 
 
 
 
For notes refer to next page.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Segmental income statement reconciliations
 
 
 
PBB
 
CPB
 
 
 
 
Central
 
 
 
Ulster
 
Commercial
Private
RBS
 
NatWest
Capital
Williams
 items &
Total
 
UK PBB
Bank RoI
 
Banking
Banking
International
 
Markets
Resolution
& Glyn
other
RBS
Quarter ended 30 September 2016
£m
£m
 
£m
£m
£m
 
£m
£m
£m
£m
£m
 
 
 
 
 
 
 
 
 
 
 
 
 
Income statement
 
 
 
 
 
 
 
 
 
 
 
 
Total income - statutory
1,336 
146 
 
849 
165 
93 
 
471 
103 
209 
(62)
3,310 
Own credit adjustments
- 
- 
 
- 
- 
- 
 
55 
42 
- 
59 
156 
Loss on redemption of own debt
- 
- 
 
- 
- 
- 
 
- 
- 
- 
(3)
(3)
Strategic disposals
- 
- 
 
- 
- 
- 
 
- 
30 
- 
1 
31 
Total income - adjusted
1,336 
146 
 
849 
165 
93 
 
526 
175 
209 
(5)
3,494 
Operating expenses - statutory
(742)
(131)
 
(474)
(112)
(39)
 
(381)
(437)
(111)
(484)
(2,911)
Restructuring costs - direct
(1)
8 
 
12 
- 
- 
 
6 
23 
12 
409 
469 
Restructuring costs - indirect
26 
3 
 
9 
3 
- 
 
27 
10 
- 
(78)
- 
Litigation and conduct costs
(1)
3 
 
6 
- 
(1)
 
6 
231 
- 
181 
425 
Operating expenses - adjusted
(718)
(117)
 
(447)
(109)
(40)
 
(342)
(173)
(99)
28 
(2,017)
Impairment (losses)/releases
(27)
39 
 
(20)
(3)
- 
 
- 
(120)
(14)
1 
(144)
Operating profit/(loss) - statutory
567 
54 
 
355 
50 
54 
 
90 
(454)
84 
(545)
255 
Operating profit/(loss) - adjusted
591 
68 
 
382 
53 
53 
 
184 
(118)
96 
24 
1,333 
 
 
 
 
 
 
 
 
 
 
 
 
 
Additional information
 
 
 
 
 
 
 
 
 
 
 
 
Return on equity (1)
27.1%
7.8%
 
9.5%
11.1%
15.4%
 
3.1%
nm
15.7%
nm
(4.8%)
Return on equity - adjusted (1,2,3)
28.3%
9.9%
 
10.4%
11.8%
15.1%
 
8.0%
nm
17.9%
nm
4.6%
Cost income ratio (4)
55.5%
89.7%
 
53.9%
67.9%
41.9%
 
80.9%
nm
53.1%
nm
87.8%
Cost income ratio - adjusted (2,3,4)
53.7%
80.1%
 
50.6%
66.1%
43.0%
 
65.0%
nm
47.4%
nm
57.3%
 
 
 
Notes:
(1)
RBS’s CET 1 target is 13% but for the purposes of computing segmental return on equity (ROE), to better reflect the differential drivers of capital usage, segmental operating profit after tax and adjusted for preference dividends is divided by average notional equity allocated at different rates of 14% (Ulster Bank RoI - 11% prior to Q1 2017), 11% (Commercial Banking), 14% (Private Banking - 15% prior to Q1 2017), 12% (RBS International) and 15% for all other segments, of the monthly average of segmental risk-weighted assets incorporating the effect of capital deductions (RWAes). RBS’s Return on equity is calculated using profit for the period attributable to ordinary shareholders.
(2)
Excluding own credit adjustments, (loss)/gain on redemption of own debt and strategic disposals.
(3)
Excluding restructuring costs and litigation and conduct costs.
(4)
Operating lease depreciation included in income (nine months ended September 2017 - £107 million; Q3 2017 - £35 million; nine months ended September 2016 - £115 million; Q2 2017 - £36 million, Q3 2016 - £39 million).
 
Legal Entity Identifier: 2138005O9XJIJN4JPN90
 
 
 
 
 
 
 
Date: 27 October 2017
 
 
 
 
 
 
THE ROYAL BANK OF SCOTLAND GROUP plc (Registrant)
 
 
 
By: /s/ Jan Cargill
 
 
 
Name: Jan Cargill
 
Title: Deputy Secretary